Literature DB >> 15817825

Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity.

Patricia Vázquez1, Isabel Roncero, Enrique Blázquez, Elvira Alvarez.   

Abstract

Several G-protein-coupled receptors contain cysteine residues in the C-terminal tail that may modulate receptor function. In this work we analysed the substitution of Cys438 by alanine in the glucagon-like peptide-1 (GLP-1) receptor (GLPR), which led to a threefold decrease in cAMP production, although endocytosis and cellular redistribution of GLP-1 receptor agonist-induced processes were unaffected. Additionally, cysteine residues in the C-terminal tail of several G-protein-coupled receptors were found to act as substrates for palmitoylation, which might modify the access of protein kinases to this region. His-tagged GLP-1 receptors incorporated 3H-palmitate. Nevertheless, substitution of Cys438 prevented the incorporation of palmitate. Accordingly, we also investigated the effect of substitution of the consensus sequence by protein kinase C (PKC) Ser431/432 in both wild-type and Ala438 GLP-1 receptors. Substitution of Ser431/432 by alanine did not modify the ability of wild-type receptors to stimulate adenylate cyclase or endocytosis and recycling processes. By contrast, the substitution of Ser431/432 by alanine in the receptor containing Ala438 increased the ability to stimulate adenylate cyclase. All types of receptors were mainly internalised through coated pits. Thus, cysteine 438 in the cytoplasmic tail of the GLP-1 receptor would regulate its interaction with G-proteins and the stimulation of adenylyl cyclase. Palmitoylation of this residue might control the access of PKC to Ser431/432.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817825     DOI: 10.1677/joe.1.06031

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

1.  Structural insight into the role of the human melanocortin 3 receptor cysteine residues on receptor function.

Authors:  Yingkui Yang; Min Chen; David McPherson; Vinod Mishra; Carroll M Harmon
Journal:  Peptides       Date:  2011-10-31       Impact factor: 3.750

Review 2.  Mechanisms of action of glucagon-like peptide 1 in the pancreas.

Authors:  Máire E Doyle; Josephine M Egan
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

Review 3.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

4.  A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification.

Authors:  Whitney M Nolte; Jean-Philippe Fortin; Benjamin D Stevens; Gary E Aspnes; David A Griffith; Lise R Hoth; Roger B Ruggeri; Alan M Mathiowetz; Chris Limberakis; David Hepworth; Philip A Carpino
Journal:  Nat Chem Biol       Date:  2014-07-06       Impact factor: 15.040

5.  NBA-Palm: prediction of palmitoylation site implemented in Naïve Bayes algorithm.

Authors:  Yu Xue; Hu Chen; Changjiang Jin; Zhirong Sun; Xuebiao Yao
Journal:  BMC Bioinformatics       Date:  2006-10-17       Impact factor: 3.169

Review 6.  Molecular Pharmacology of the Incretin Receptors.

Authors:  Suleiman Al-Sabah
Journal:  Med Princ Pract       Date:  2015-06-20       Impact factor: 1.927

7.  Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.

Authors:  Teresa Buenaventura; Stavroula Bitsi; William E Laughlin; Thomas Burgoyne; Zekun Lyu; Affiong I Oqua; Hannah Norman; Emma R McGlone; Andrey S Klymchenko; Ivan R Corrêa; Abigail Walker; Asuka Inoue; Aylin Hanyaloglu; Jak Grimes; Zsombor Koszegi; Davide Calebiro; Guy A Rutter; Stephen R Bloom; Ben Jones; Alejandra Tomas
Journal:  PLoS Biol       Date:  2019-08-20       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.